SCHEMBL470708

SCHEMBL470708

COc1c(O)cccc1C(=O)O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 5/20 0.54
CA2 P00918 5/20 0.54
ALDH1A1 P00352 5/20 0.54
KDM4E B2RXH2 4/20 0.54
HPGD P15428 4/20 0.54
CA12 O43570 4/20 0.54
CA7 P43166 4/20 0.54
CA9 Q16790 4/20 0.54
CA14 Q9ULX7 4/20 0.54
HMGB1 P09429 1/20 0.54
CA4 P22748 1/20 0.54
CA6 P23280 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
NAPRT Q6XQN6 1/20 0.54
G6PD P11413 1/20 0.52
CASP7 P55210 1/20 0.52
CASP6 P55212 1/20 0.52
MAPT P10636 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
HSD17B10 Q99714 3/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL39857 0.87 ALDH1A1 (0.55) CA1CA2ALDH1A1KDM4EHPGD
Hydrochloric Acid SCHEMBL699717 0.85 ALDH1A1 (0.53) CA1CA2ALDH1A1KDM4EHPGD
SCHEMBL20342786 0.84 CA1 (0.52) CA1CA2ALDH1A1KDM4EHPGD
Methyl 3-Hydroxy-2-Methoxybenzoate SCHEMBL1050662 0.82 LMNA (0.66) CA1CA2ALDH1A1KDM4EHPGD
SCHEMBL302637 0.82 LMNA (0.55) CA1CA2ALDH1A1KDM4EHPGD
SCHEMBL367775 0.82 ALDH1A1 (0.56) CA1CA2ALDH1A1KDM4EHPGD
SCHEMBL30675634 0.82 ALDH1A1 (0.70) CA1CA2ALDH1A1KDM4EHPGD
SCHEMBL305252 0.82 ALDH1A1 (0.70) CA1CA2ALDH1A1KDM4EHPGD
SCHEMBL419245 0.82 TDP1 (0.56) CA1CA2ALDH1A1KDM4ECA12
SCHEMBL8676658 0.81 KDM4E (0.69) CA1CA2ALDH1A1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 210 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12076316-B2 Levorphanol prodrugs and processes for making and using them ZEVRA THERAPEUTICS INC. 2024-09-03 US claimed
US-20220096463-A1 LEVORPHANOL PRODRUGS AND PROCESSES FOR MAKING AND USING THEM ALTER DOMUS (US) LLC 2022-03-31 US claimed
US-11234975-B2 Levorphanol prodrugs and processes for making and using them KEMPHARM, INC. (US) 2022-02-01 US claimed
US-11220650-B2 Grease composition SHELL OIL COMPANY (US) 2022-01-11 US claimed
US-11198830-B2 Grease composition SHELL OIL COMPANY (US) 2021-12-14 US claimed
US-20200390757-A1 LEVORPHANOL PRODRUGS AND PROCESSES FOR MAKING AND USING THEM ALTER DOMUS (US) LLC 2020-12-17 US claimed
WO-2018191474-A1 LEVORPHANOL PRODRUGS AND PROCESSES FOR MAKING AND USING THEM KEMPHARM, INC. (US) 2018-10-18 WO claimed
US-20170312270-A1 BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF OXYMORPHONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF ALTER DOMUS (US) LLC 2017-11-02 US claimed
EP-3226907-A1 BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF OXYMORPHONE, PRODRUGS, METHODS AND MAKING AND USE THEREOF Kempharm, Inc. (US) 2017-10-11 EP claimed
EP-3223819-A1 BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF OXYCODONE Kempharm, Inc. (US) 2017-10-04 EP claimed
CN-103124759-A Functional biodegradable polymers UNIV AKRON 2013-05-29 CN claimed
WO-2013063204-A1 BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF HYDROMORPHONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF KEMPHARM, INC. (US) 2013-05-02 WO claimed
WO-2013016668-A2 METHYLPHENIDATE-PRODRUGS, PROCESSES OF MAKING AND USING THE SAME KEMPHARM INC. (US) 2013-01-31 WO claimed
EP-2470632-A1 IMPROVED WASHING PERFORMANCE USING RADICAL TRAPS Henkel AG & Co. KGaA (DE) 2012-07-04 EP claimed
US-20120157370-A1 WASHING PERFORMANCE USING RADICAL TRAPS HENKEL AG & CO. KGAA (DE) 2012-06-21 US claimed
US-20120142719-A1 Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof ALTER DOMUS (US) LLC 2012-06-07 US claimed
CN-102480959-A Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof KEMPHARM INC 2012-05-30 CN claimed
EP-2448407-A1 BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF HYDROCODONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF Kempharm, Inc. (US) 2012-05-09 EP claimed
WO-2011023716-A1 IMPROVED WASHING PERFORMANCE USING RADICAL TRAPS HENKEL AG & CO. KGAA (DE) 2011-03-03 WO claimed
US-20110002990-A1 BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF HYDROCODONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF ALTER DOMUS (US) LLC 2011-01-06 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200390757-A1 LEVORPHANOL PRODRUGS AND PROCESSES FOR MAKING AND USING THEM OPRM1, OPRL1, OPRK1 CA1 1503/4885CA2 3018/4885ALDH1A1 1258/4885
US-20170312270-A1 BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF OXYMORPHONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF OPRM1, OPRK1, OPRD1 CA1 1451/4885CA2 1603/4885ALDH1A1 125/4885
US-12076316-B2 Levorphanol prodrugs and processes for making and using them OPRM1, OPRL1, OPRK1 CA1 1503/4885CA2 3018/4885ALDH1A1 1258/4885
US-11234975-B2 Levorphanol prodrugs and processes for making and using them OPRM1, OPRL1, OPRK1 CA1 1503/4885CA2 3018/4885ALDH1A1 1258/4885
US-20110002990-A1 BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF HYDROCODONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF CYP2B6, CYP3A43, CYP2D6 CA1 1685/4885CA2 1960/4885ALDH1A1 160/4885
US-20120142719-A1 Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof CYP2B6, CYP3A43, CYP2D6 CA1 1685/4885CA2 1960/4885ALDH1A1 160/4885
US-20120157370-A1 WASHING PERFORMANCE USING RADICAL TRAPS MPO, DNASE1, PLD4 CA1 3982/4885CA2 3871/4885ALDH1A1 1226/4885
US-20220096463-A1 LEVORPHANOL PRODRUGS AND PROCESSES FOR MAKING AND USING THEM OPRM1, OPRL1, OPRK1 CA1 1503/4885CA2 3018/4885ALDH1A1 1258/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.